Account Login/Registration

Access PrinceGeorgeNow using your Facebook account, or by entering your information below.


Facebook


OR


Register

Privacy Policy

Health Canada seizes unauthorized prescription drug being sold in BC

Health Canada has seized an unauthorized prescription product being sold in B.C.

They are advising consumers that the unauthorized product "Kobayashi Aibon/Eyebon Eyewash" is labelled to contain a prescription drug, aminocaproic acid, and may pose serious health risks.

<who>Photo Credit: Health Canada

The product is promoted as an eyewash for contact lens users and for the prevention of eye disease.

Aminocaproic acid is a prescription drug ingredient used to decrease bleeding in various clinical situations, say Health Canada. Exposure to aminocaproic acid in the eye may affect the eye itself, and the acid may be absorbed through the tear ducts into the blood. Side effects may include watery eyes, vision changes, headache, dizziness, nausea, muscle weakness, and skin rash.

Health Canada seized two formats, "Cool" and "Mild," from a Tokyo Beauty & Health Care retail location in Richmond, at 120 - 8191 Westminster Highway.

“Prescription drugs should be taken only under the advice and supervision of a healthcare professional because they are used in relation to specific diseases, and may cause serious side effects,” said Health Canada. “The unauthorized health product was packaged and labelled in Japanese ("Eyebon" may also be translated as "Aibon"). As a result, information about ingredients, usage, dosage and side effects may not be understood by all consumers.”

Selling unauthorized health products in Canada is illegal. Health Canada previously warned about this product after it was seized at a different retail store in 2017.



Send your comments, news tips, typos, letter to the editor, photos and videos to [email protected].




weather-icon
Fri
3℃

weather-icon
Sat
7℃

weather-icon
Sun
14℃

weather-icon
Mon
9℃

weather-icon
Tue
12℃

weather-icon
Wed
6℃

Top Stories

Follow Us

Follow us on Instagram Follow us on Twitter Like us on Facebook Follow us on Linkedin
Follow Our Newsletter
Privacy Policy